These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 20090525)
21. Evaluating the Safety and Efficacy of Erythropoietin Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis. Marsia S; Kumar D; Raheel H; Salman A; Aslam B; Ikram A; Kumar P; Aslam A; Shafiq A; Gul A Pediatr Neurol; 2024 Mar; 152():4-10. PubMed ID: 38171084 [TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effects of erythropoietin on hypoxic-ischemic encephalopathy in neonates]. Wang YJ; Pan KL; Zhao XL; Qiang H; Cheng SQ Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):855-8. PubMed ID: 22099189 [TBL] [Abstract][Full Text] [Related]
23. Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia. Spandou E; Soubasi V; Papoutsopoulou S; Karkavelas G; Simeonidou C; Kaiki-Astara A; Guiba-Tziampiri O Neurosci Lett; 2004 Aug; 366(1):24-8. PubMed ID: 15265583 [TBL] [Abstract][Full Text] [Related]
24. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use. Perrone S; Lembo C; Gironi F; Petrolini C; Catalucci T; Corbo G; Buonocore G; Gitto E; Esposito SMR Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453337 [TBL] [Abstract][Full Text] [Related]
25. Perinatal Asphyxia and Erythropoietin and VEGF: Serial Serum and Cerebrospinal Fluid Responses. Sweetman DU; Onwuneme C; Watson WR; Murphy JF; Molloy EJ Neonatology; 2017; 111(3):253-259. PubMed ID: 27902983 [TBL] [Abstract][Full Text] [Related]
26. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Fan X; Heijnen CJ; van der KOOIJ MA; Groenendaal F; van Bel F Pediatr Res; 2011 Jan; 69(1):56-61. PubMed ID: 20856165 [TBL] [Abstract][Full Text] [Related]
27. Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat? van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F Neurosci Lett; 2009 Feb; 451(2):109-13. PubMed ID: 19103262 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental Outcome. Mulkey SB; Ramakrishnaiah RH; McKinstry RC; Chang T; Mathur AM; Mayock DE; Van Meurs KP; Schaefer GB; Luo C; Bai S; Juul SE; Wu YW J Pediatr; 2017 Jul; 186():196-199. PubMed ID: 28456387 [TBL] [Abstract][Full Text] [Related]
30. Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway. Yu DF; Zhu LH; Jiang L Chin Med J (Engl); 2017 Apr; 130(7):854-858. PubMed ID: 28345550 [TBL] [Abstract][Full Text] [Related]
31. Erythropoietin reduces hippocampus injury in neonatal rats with hypoxic ischemic brain damage via targeting matrix metalloprotein-2. Zhang L; Wang L; Ning FB; Wang T; Liang YC; Liu YL Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4327-4333. PubMed ID: 29077163 [TBL] [Abstract][Full Text] [Related]
32. Utilization of Erythropoietin within the United States Neonatal Intensive Care Units from 2008 to 2017. Ahmad KA; Bennett MM; Juul SE; Ohls RK; Clark RH; Tolia VN Am J Perinatol; 2021 Jun; 38(7):734-740. PubMed ID: 31858498 [TBL] [Abstract][Full Text] [Related]
33. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Iwai M; Stetler RA; Xing J; Hu X; Gao Y; Zhang W; Chen J; Cao G Stroke; 2010 May; 41(5):1032-7. PubMed ID: 20360553 [TBL] [Abstract][Full Text] [Related]
34. Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand. Garg B; Sharma D; Bansal A J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3214-3224. PubMed ID: 28797191 [TBL] [Abstract][Full Text] [Related]
35. Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy. Choi JW; Kang SJ; Choi JI; Kwack K; Kim M Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270042 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents. Alexander ML; Hill CA; Rosenkrantz TS; Fitch RH Dev Neurosci; 2012; 34(6):515-24. PubMed ID: 23328535 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotection with erythropoietin in preterm and/or low birth weight infants. Zhang J; Wang Q; Xiang H; Xin Y; Chang M; Lu H J Clin Neurosci; 2014 Aug; 21(8):1283-7. PubMed ID: 24650681 [TBL] [Abstract][Full Text] [Related]
39. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F Brain Res Rev; 2008 Nov; 59(1):22-33. PubMed ID: 18514916 [TBL] [Abstract][Full Text] [Related]
40. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial. Malla RR; Asimi R; Teli MA; Shaheen F; Bhat MA J Perinatol; 2017 May; 37(5):596-601. PubMed ID: 28277490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]